Trial
NCT02452775
Autologous OC-L Vaccine and Ovarian Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Ovarian Cancer Research Center
Condition
Primary Ovarian Cancer
Intervention
OC-L
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-24